Research highlights of the 2020 society of urologic oncology young urologic oncologists' program.
作者信息
Klaassen Zachary, Scarpato Kristen R, Ristau Benjamin T, Stratton Kelly L, Porten Sima P, Smaldone Marc C, Chapin Brian F, Psutka Sarah P
机构信息
Division of Urology, Augusta University - Medical College of Georgia, Augusta, GA; Georgia Cancer Center, Augusta, GA.
Department of Urology, Vanderbilt University, Nashville, TN.
出版信息
Urol Oncol. 2021 Aug;39(8):452-454. doi: 10.1016/j.urolonc.2021.03.020. Epub 2021 Apr 12.
Abstract
摘要
相似文献
1
Research highlights of the 2020 society of urologic oncology young urologic oncologists' program.2020年泌尿肿瘤学会青年泌尿肿瘤学家项目的研究亮点
Urol Oncol. 2021 Aug;39(8):452-454. doi: 10.1016/j.urolonc.2021.03.020. Epub 2021 Apr 12.
2
Highlights from the Society of Urologic Oncology, 5th Annual Meeting, December 3-4, 2004, Bethesda, Maryland, United States of America.美国泌尿外科肿瘤学会第五届年会亮点，2004年12月3日至4日，美国马里兰州贝塞斯达。
J Urol. 2005 Dec;174(6):2330-3. doi: 10.1097/01.ju.0000181828.95803.94.
3
Report from the 1st Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2006: 'A step towards better collaboration between urologists and medical oncologists'.2006年日本泌尿外科学会-日本医学肿瘤学会首次联合会议报告：“泌尿外科医生与医学肿瘤学家迈向更好合作的一步”
Int J Urol. 2007 May;14(5):375-83. doi: 10.1111/j.1442-2042.2007.01815.x.
4
Report from the second Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2007: 'diagnosis and treatment of urological malignant tumors: how can we promote subspecialists?'.日本泌尿外科学会 - 日本医学肿瘤学会2007年第二次联合会议报告：“泌尿生殖系统恶性肿瘤的诊断与治疗：我们如何推动专科医生发展？”
Int J Urol. 2008 May;15(5):389-93. doi: 10.1111/j.1442-2042.2008.02037.x.
5
Developments in urologic oncology 'OncoForum': The best of 2014.泌尿肿瘤学进展“肿瘤论坛”：2014年精华
Actas Urol Esp. 2015 Jun;39(5):271-8. doi: 10.1016/j.acuro.2015.02.004. Epub 2015 Mar 12.
6
[Urologic oncology].[泌尿外科肿瘤学]
Wien Med Wochenschr. 2011 Aug;161(15-16):365. doi: 10.1007/s10354-011-0024-5.
7
Role of Geriatric Oncologists in Optimizing Care of Urological Oncology Patients.老年肿瘤学家在优化泌尿外科肿瘤患者护理中的作用。
Eur Urol Focus. 2017 Oct;3(4-5):385-394. doi: 10.1016/j.euf.2017.10.012. Epub 2017 Nov 8.
8
Adolescent urologic oncology: current issues and future directions.青少年泌尿生殖系统肿瘤学：当前问题与未来方向
Urol Oncol. 2014 Feb;32(2):59-69. doi: 10.1016/j.urolonc.2012.08.002. Epub 2012 Nov 8.
9
Urologic oncology in the twenty-first century.21世纪的泌尿外科肿瘤学。
World J Surg. 2000 Oct;24(10):1167-71. doi: 10.1007/s002680010196.
10
Trends in the use of administrative databases in urologic oncology: 2000-2019.泌尿科肿瘤学中使用行政数据库的趋势：2000-2019 年。
Urol Oncol. 2021 Aug;39(8):487-492. doi: 10.1016/j.urolonc.2021.01.014. Epub 2021 Feb 5.
引用本文的文献
1
Mechanisms, Clinical Trials, and New Treatments for BCG-Unresponsive in Nonmuscle Invasive Bladder Cancer.非肌层浸润性膀胱癌卡介苗无反应的机制、临床试验及新疗法
Cancer Med. 2025 Sep;14(18):e71243. doi: 10.1002/cam4.71243.
本文引用的文献
1
Cancer Statistics, 2021.癌症统计数据，2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
2
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.纳武拉非尼基因导管治疗卡介苗无应答性非肌肉浸润性膀胱癌：一项单臂、开放标签、重复剂量临床试验。
Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S1470-2045(20)30540-4. Epub 2020 Nov 27.
3
Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer.患者报告的与局部前列腺癌当代治疗相关的经济毒性。
J Urol. 2021 Mar;205(3):761-768. doi: 10.1097/JU.0000000000001423. Epub 2020 Nov 30.
4
COVID-19 and financial toxicity in patients with renal cell carcinoma.COVID-19 与肾细胞癌患者的财务毒性。
World J Urol. 2021 Jul;39(7):2559-2565. doi: 10.1007/s00345-020-03476-6. Epub 2020 Oct 22.
5
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.根治性前列腺切除术后局部前列腺癌男性患者的辅助放疗与早期挽救性放疗加短期雄激素剥夺治疗的比较（GETUG-AFU 17）：一项随机、3 期试验。
Lancet Oncol. 2020 Oct;21(10):1341-1352. doi: 10.1016/S1470-2045(20)30454-X.
6
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.辅助放疗与根治性前列腺切除术后早期挽救性放疗（TROG 08.03/ANZUP RAVES）：一项随机、对照、3 期、非劣效性试验。
Lancet Oncol. 2020 Oct;21(10):1331-1340. doi: 10.1016/S1470-2045(20)30456-3.
7
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.辅助或早期挽救性放疗治疗局限性和局部进展性前列腺癌：汇总数据的前瞻性计划系统评价和荟萃分析。
Lancet. 2020 Oct 31;396(10260):1422-1431. doi: 10.1016/S0140-6736(20)31952-8. Epub 2020 Sep 28.
8
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.根治性前列腺切除术后放疗时机（RADICALS-RT）：一项随机对照 3 期试验。
Lancet. 2020 Oct 31;396(10260):1413-1421. doi: 10.1016/S0140-6736(20)31553-1. Epub 2020 Sep 28.
9
Epidemiology of Renal Cell Carcinoma.肾细胞癌的流行病学
World J Oncol. 2020 Jun;11(3):79-87. doi: 10.14740/wjon1279. Epub 2020 May 14.
10
Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018.成年人肥胖和重度肥胖的患病率：美国，2017-2018 年。
NCHS Data Brief. 2020 Feb(360):1-8.
Zotero 插件